2Maurizio Salvadori etc.Enteric-Coated Myeophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novo Renal Transplant Patients[J].American Journal of Transplantation,2003,4:231-236.
3Matthew Cooper etc.Comparing Outcomes Associated With Dose Manipulations of Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients[J].Transplantation,2009,88(4):514-520.
4Gaetano Ciancio etc.Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/ Thymoglobulin:One Year Follow-Up[J].Transplantation,2008,86(1):67-74.
5William Irish etc.Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil Maintenance Immunosuppression:Outcomes Analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network Database[J].Transplantation,2010,90:23-30.
6Hans W.Sollinger etc.Mycophenolate Mofetii Versus EntericCoated Mycophenolate Sodium:A Large,Single-Center Comparison of Dose Adjustments and Outcomes in Kidney Transplant Recipients[J].Transplantation,2010,89(4):446-451.
7Klemens Budde etc.Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients:Results of a 1-Year Study[J].American Journal of Transplantation,2003,4:237-243.
8Torsten Brhler etc.Pharmacodynamic monitoring of the conversion from mycophenolatemofetil to enteric-coatedmycopheno-late sodium in stable kidney-allograft recipients[J].International Immunopharmacology,2008,8:769-773.
9B Nashan etc.Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Maintenance Renal Transplant Patients:Preliminary Results From the myfortic Prospective Multicenter Study.Transplantation Proceedings,2004,36(Suppl 2S):521 S-523S.
10P Massari etc.Safety Assessment of the Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Stable Renal Transplant Recipients.Transplantation Proceedings,2005,37:916-919.
1Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients: results of the DIDACT study. Am J Trans- plant,2006,6 (6) : 1466-1472.
2Brister K,Yau CL, Stakey D. Entenc coating of mycophenolate re- duces dosage adjustments. Transplant Proc, 2009,41 ( 5 ) : 1657- 1659.
3Langone A J, Chan L, Bolin P, et al. Entenc-coated mycophenolate sodium versus mycophenolate Mofetil in renal tranplant recipients expenencing gastrintestinal intolerance : a muiticenter, double-blindrandomized study, Transplantation ,2011,91 (4) :470-478.
4Sollinger HW, Sundberg AK , Leverson G, et al. Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium: A Large, Single-Center Comparison of Dose Adjustments and Outcomes in Kidney Transplant Recipients. Transplantation,2010,89 ( 4 ) : 446 - 451.
5Irish W, Arcona S, Gifford R, et al. Enteric-coated mycophenolate sodium versus mycophenolate mofetil maintenance immunosuppres- sion: outcomes analysis of the United Network for Organ Sharing/ Organ Procurement and Transplantation Network database. Trans- plantation ,2010,90( 1 ) :23-30.
